Trevor Lin

Trevor Lin

Auto-generated profile, based on publicly available information

Trevor Lin

Morsani College of Medicine, University of South Florida, Tampa, Florida, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2026 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
KLKyoung A Viola Lee
Kyoung A Viola Lee
CLCarsten Langholm
Carsten Langholm
TLTrevor Lin
Trevor Lin
KJKimberly Jin
Kimberly Jin
IAInas F Aboobakar
Inas F Aboobakar
MWMary C Whitman
Mary C Whitman
Aims: To evaluate the adult health consequences of amblyopia, including sensory deficits, mental health, physical activity and cardiovascular health. Methods: A cross-sectional study using data from the National Institutes of Health’s All of Us Research Program, including 1998 adults with amblyopia (1335 non-strabismic, 663 strabismic) identified by International Classification of Diseases (ICD)-9/ICD-10/Systemized Nomenclature of Medicine (SNOMED) codes, including 187 with Fitbit data. Controls (10:1 ratio) were propensity-score-matched on age, sex, self-reported race, income and healthcare visits. Separate matched control groups were used for Fitbit and subgroup analyses. Data from electronic health records, surveys and Fitbit were used to assess sensory impairments, cardiometabolic conditions, physical activity and neuropsychiatric disorders. Prevalence and ORs with 95% CIs were calculated to assess associations between amblyopia (total, strabismic and non-strabismic) and health outcomes. Results: Amblyopia was associated with increased odds of bilateral blindness (OR=2.96, 95% CI 2.54 to 3.44), obesity (OR=1.27, 95% CI 1.16 to 1.39), type 2 diabetes (OR=1.39, 95% CI 1.26 to 1.53) and cardiovascular disease (OR=1.92, 95% CI 1.69 to 2.19). Amblyopic individuals took fewer daily steps (5859 vs 6229; p=0.044), indicating decreased physical activity. Neuropsychiatric disorders were more common, including generalised anxiety (OR=1.57, 95% CI 1.43 to 1.72), substance use disorder (OR=1.40, 95% CI 1.25 to 1.55), bipolar disorder (OR=1.35, 95% CI 1.13 to 1.61), attention-deficit/hyperactivity disorder (OR=1.54, 95% CI 1.28 to 1.86), obsessive compulsive disorder (OR=1.82, 95% CI 1.31 to 2.54) and autism (OR=3.27, 95% CI 1.79 to 5.99). Schizophrenia was not associated (OR=1.00, 95% CI 0.70 to 1.42). Conclusions: Amblyopia is associated with long-term systemic health conditions, suggesting either long-term effects of visual impairment or shared underlying risk factors. These findings underscore the need for early detection and intervention. Further research is needed to explore the neurodevelopmental pathways linking amblyopia and its comorbidities.

7 January 2025 in Advances in Ophthalmology Practice and Research
Verified
Journal Article
Open access
TLTrevor Lin
Trevor Lin
RLRyan T. Lin
Ryan T. Lin
RMRahul Mhaskar
Rahul Mhaskar
CMCurtis E. Margo
Curtis E. Margo

7 April 2026 in Journal of Clinical Lipidology
Verified
Journal Article
Open access
PBPaula Byrne
Paula Byrne
TLTrevor Lin
Trevor Lin
MJMark Jones
Mark Jones
MDMaryanne Demasi
Maryanne Demasi
KSK.M. Saif-Ur-Rahman
K.M. Saif-Ur-Rahman
RDRobert Dubroff
Robert Dubroff
Despite extensive efforts to lower low-density lipoprotein cholesterol (LDL-C), cardiovascular disease remains highly prevalent. Remnant cholesterol (RC) has been proposed as a potentially more relevant therapeutic target. To evaluate the association between RC reduction and cardiovascular outcomes in randomized controlled trials (RCTs) of cholesterol- and triglyceride-lowering therapies, assessing whether RC independently influences cardiovascular risk. Cochrane Central and Embase were searched for RCTs with ≥1000 participants and ≥2 years' planned duration that assessed cholesterol- or triglyceride-lowering therapies vs placebo, usual care, or other lipid-lowering drugs in adults. Two reviewers independently extracted data and evaluated methodological quality. Meta-analysis and meta-regression were performed. Forty-three RCTs met the inclusion criteria; most had some risk of bias, and evidence certainty was moderate. Meta-analysis showed absolute risk reductions of 0.4% (95% CI 0.1%-0.6%) for all-cause mortality, 1.3% (95% CI 1.1%-1.6%) for myocardial infarction, and 0.4% (95% CI 0.2%-0.6%) for stroke in treatment vs control groups. Meta-regression demonstrated no association between RC reduction and any clinical outcome, whereas LDL-C and non-high-density lipoprotein cholesterol reductions were associated with risk reduction. RC reduction was not associated with cardiovascular benefit. This contrasts with observational and Mendelian randomization studies, likely reflecting methodological differences; MR estimates lifelong genetically mediated exposure and may not reliably predict the effects of short-term pharmacological lipid lowering. In a review of 43 large clinical trials, lowering "remnant cholesterol" did not reduce heart attacks, strokes, or deaths - unlike lowering LDL ("bad") cholesterol, which did - suggesting that remnant cholesterol may not be a useful treatment target despite earlier studies hinting otherwise.Summary sentence A review of 43 clinical trials found that lowering remnant cholesterol did not translate into fewer deaths, heart attacks, or strokes.

6 June 2025 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
TLTrevor Lin
Trevor Lin
LHLynn E. Harman
Lynn E. Harman
CMCurtis E. Margo
Curtis E. Margo

23 May 2024 in Radiology Case Reports
Verified
Journal Article
Open access
JKJoe Khoury
Joe Khoury
BLBrenden Li
Brenden Li
JZJoyce Jiawei Zhu
Joyce Jiawei Zhu
TLTrevor Lin
Trevor Lin
EHEusha Hasan
Eusha Hasan
MAMustafa Al-Roubaie
Mustafa Al-Roubaie
Radiation induced cholecystitis is a known but rare complication of Yttrium90 (Y90) radioembolization of hepatic tumors due to nontarget embolization. Many documented cases of radiation induced cholecystitis have been treated with cholecystectomy, which is significant given the typical patient population undergoing radioembolization tends to be of higher surgical risk. Here, we present a case of a 68 year old male who developed radiation induced cholecystitis status post hepatic radioembolization that resolved with conservative management alone. This case highlights that radiation induced cholecystitis may be successfully and safely treated conservatively.

9 July 2026 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
TLTrevor Lin
Trevor Lin
SCSteven M Cohen
Steven M Cohen
Chronic subretinal fluid (SRF) is a common complication of dome-shaped macula (DSM), yet its optimal management remains uncertain. This paper presents a case of spontaneous resolution of chronic SRF associated with DSM following discontinuation of anti-vascular endothelial growth factor (anti-VEGF) therapy. The patient, in her late 70s, with DSM and chronic SRF in the left eye was treated with multiple anti-VEGF agents, including ranibizumab, aflibercept and faricimab, over 19 months. Despite ongoing therapy, her SRF persisted and best-corrected visual acuity (BCVA) remained stable at 20/20 to 20/25. 45 days after treatment cessation, optical coherence tomography showed complete resolution of SRF. Over 26 months of subsequent observation without further treatment, the retina remained dry and BCVA remained stable. This suggests that in DSM, chronic SRF refractory to anti-VEGF therapy may spontaneously resolve after discontinuing treatment. Observation is a reasonable management strategy in specific patients to minimise unnecessary injections and associated risks.